Autism spectrum disorder affects children and families worldwide, but prevalence and reporting can vary by region and diagnostic criteria. In the United States, diagnosis is identified about four times more often in boys than girls, and many children can be screened in early childhood. This page guides you through key themes—core behaviors like repetitive patterns, common features such as sensory sensitivities, and frequent co-occurring conditions—then connects them to assessment tools and what early support can influence.
Key Takeaways
- Approximately 31% of individuals with ASD have an intellectual disability (IQ<70), per CDC 2020 ADDM data
- Sensory sensitivities affect 96% of children with ASD per 2018 review
- 28% of children with ASD have co-occurring epilepsy per 2020 meta-analysis
- Average age of ASD diagnosis in U.S. is 4 years 6 months per CDC 2020
- M-CHAT screening at 18-24 months detects 85% ASD risk toddlers
- ADOS-2 gold standard diagnostic tool sensitivity 91%, specificity 84%
- In the United States, about 1 in 36 children aged 8 years was identified with autism spectrum disorder (ASD) in 2020 according to the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network
- Globally, autism prevalence is estimated at 1 in 100 children by the World Health Organization, with variations by region and diagnostic criteria
- In the UK, ASD prevalence among children is approximately 1.76% or 1 in 57, based on a 2017 National Autistic Society survey
- Heritability of ASD estimated at 80% from twin studies
- Over 100 genes associated with ASD risk per SFARI Gene database 2023
- De novo mutations contribute 10-30% ASD cases per exome sequencing
- Intensive ABA therapy 20-40 hours/week improves IQ 15-20 points average
- Early Start Denver Model (ESDM) at 12-48 months gains 17 IQ points
- Risperidone reduces irritability 69% in ASD youth per RUPP trial
Most children with ASD face sensory and behavioral challenges early, with earlier screening and targeted therapies improving outcomes.
Related reading
01 · Category
Clinical Characteristics30 stats
01
Approximately 31% of individuals with ASD have an intellectual disability (IQ<70), per CDC 2020 ADDM data
02
Sensory sensitivities affect 96% of children with ASD per 2018 review
03
28% of children with ASD have co-occurring epilepsy per 2020 meta-analysis
04
Repetitive behaviors occur in 88% of ASD individuals per DSM-5 criteria studies
05
Social communication deficits are core to 100% of ASD diagnoses per DSM-5
06
40-80% of ASD children experience sleep disturbances per 2019 review
07
Gastrointestinal issues affect 23-70% of ASD children vs 9% typically developing
08
Anxiety disorders comorbid in 40% of ASD adults per 2021 study
09
ADHD co-occurs in 28-44% of ASD cases per CDC data
10
Self-injurious behaviors in 50% of ASD with intellectual disability per review
11
Echolalia present in 75% of verbal ASD children early on per studies
12
70% of ASD individuals have motor coordination deficits per 2019 meta-analysis
13
Wandering/elopement risk in 49% of ASD children per 2012 study
14
Depression rates 4x higher in ASD adults at 20-40% per reviews
15
Hyper/hyposensitivity to sound in 92.8% of ASD per 2018 survey
16
OCD comorbidity in 17% of ASD per 2020 meta-analysis
17
Feeding problems in 24-39% ASD toddlers per studies
18
Visual processing atypicalities in 68% ASD per neuroimaging
19
Aggression in 68% of verbal ASD adolescents per 2013 study
20
Prosody atypical in 86% ASD speakers per 2018 review
21
Rumination in 19% ASD vs 1% controls per 2019 study
22
Tics in 11% ASD children per large cohort
23
Joint hypermobility 20% higher in ASD per 2020 study
24
Irritability scores 2x higher in ASD per ABC scales
25
Theory of mind deficits in 80% high-functioning ASD per tests
26
Executive function impairment in 80% ASD per meta-analysis
27
Schizotypy traits elevated in 50% ASD adults
28
Pain hyposensitivity in 56% ASD per caregiver reports
29
Central coherence weak in 70% ASD per tasks
30
32% ASD children non-verbal by age 8 per CDC
Interpretation
Clinical Characteristics Interpretation
Clinical characteristics of ASD are highly common and wide ranging, with sensory sensitivities affecting 96% of children and sleep disturbances reported in 40 to 80%, showing that many needs go beyond social communication and appear across everyday functioning.
02 · Category
Diagnosis And Assessment30 stats
01
Average age of ASD diagnosis in U.S. is 4 years 6 months per CDC 2020
02
M-CHAT screening at 18-24 months detects 85% ASD risk toddlers
03
ADOS-2 gold standard diagnostic tool sensitivity 91%, specificity 84%
04
52% U.S. children with ASD evaluated by age 3 per 2020 CDC
05
Girls diagnosed 1.5 years later than boys average per studies
06
Early diagnosis before 3 years improves outcomes 50% per meta-analysis
07
SCQ screening tool sensitivity 85% for ASD over 4 years
08
Black children diagnosed 1.5 years later than White per U.S. data
09
ESI-R identifies 50% developmental delay at 12 months including ASD
10
High-risk infant sibling studies diagnose ASD by 14 months accuracy 80%
11
DSM-5 criteria increased diagnosis rates 20% vs DSM-IV
12
Eye-tracking biomarkers predict ASD 81% accuracy at 6 months
13
CARS rating scale inter-rater reliability 0.71 for ASD severity
14
Only 42% Medicaid ASD children screened by 24 months per 2019 study
15
qEEG patterns classify ASD 89% accuracy per 2020 review
16
STAT screening 92% sensitivity for toddlers 24-36 months
17
Rural children ASD diagnosis age 8.5 years vs urban 7.3 per U.S.
18
Machine learning on videos predicts ASD 88% at 12 months
19
ASRS for adults sensitivity 0.91, specificity 0.97
20
Head circumference growth abnormal predicts 80% ASD by 12 months
21
Parental concern age average 18 months but diagnosis 3 years delay
22
fMRI social brain differences 95% classify ASD vs controls
23
CSBS-IT identifies 90% communication delay pre-ASD diagnosis
24
Girls require more symptoms for diagnosis per criteria bias studies
25
Salivary oxytocin levels biomarker low in 70% ASD
26
ITSEA flags 83% ASD risk at 9-18 months
27
Diagnostic stability 83% from 14-24 months per BABY SIBS
28
AQ-10 screening adults sensitivity 0.89 UK primary care
29
Earliest reliable diagnosis at 18 months with ADOS-T 77% accuracy
30
70% ASD adults undiagnosed per U.S. estimates
Interpretation
Diagnosis And Assessment Interpretation
In the diagnosis and assessment of autism, the evidence shows that early screening and gold-standard testing are making a difference, with the U.S. average diagnosis at 4 years 6 months and early identification before age 3 improving outcomes by 50 percent.
03 · Category
Epidemiology And Prevalence30 stats
01
In the United States, about 1 in 36 children aged 8 years was identified with autism spectrum disorder (ASD) in 2020 according to the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network
02
Globally, autism prevalence is estimated at 1 in 100 children by the World Health Organization, with variations by region and diagnostic criteria
03
In the UK, ASD prevalence among children is approximately 1.76% or 1 in 57, based on a 2017 National Autistic Society survey
04
ASD diagnosis rates in boys are 4 times higher than in girls, with a ratio of about 4:1 according to CDC ADDM 2020 data
05
In South Korea, a 2011 study found an ASD prevalence of 2.64% or 1 in 38 children aged 7-12 years
06
Autism prevalence has increased from 1 in 150 in 2000 to 1 in 36 in 2020 per CDC surveillance, reflecting better awareness and diagnosis
07
Among U.S. children, 1 in 44 8-year-olds had ASD in 2018 per CDC ADDM
08
In Australia, ASD prevalence is estimated at 1 in 70 children under 7 years from 2018 data
09
European studies show ASD prevalence around 1% or 1 in 100, per a 2018 systematic review
10
In California, ASD prevalence among 8-year-olds was 4.5% in 2018 per Department of Developmental Services
11
U.S. Black children had ASD prevalence of 1 in 46 in 2020, similar to White children at 1 in 36 per CDC
12
In Sweden, ASD diagnosis rates reached 1.5% by 2015 in national registries
13
Asian/Pacific Islander U.S. children have ASD rates of 1 in 42 per 2020 CDC data
14
Lifetime cost of supporting an individual with ASD is $1.4–2.4 million USD per CDC 2014 estimate adjusted for inflation
15
In Japan, ASD prevalence is about 3% among school-aged children per 2016 study
16
U.S. Hispanic children ASD prevalence is 1 in 45 per 2020 CDC ADDM
17
In Canada, ASD prevalence is 1 in 66 children aged 5-17 per 2018 Public Health Agency
18
Female ASD underdiagnosis leads to 7:1 male ratio in adults per UK studies
19
In India, ASD prevalence estimates range 1 in 100 to 1 in 500 due to underdiagnosis
20
U.S. adults with ASD estimated at 2.21% or 5.4 million per 2020 JAMA study
21
In China, urban ASD prevalence is 1 in 143 children per 2019 meta-analysis
22
New Jersey U.S. site had highest ASD prevalence at 1 in 28 per CDC 2020
23
In France, ASD prevalence is 0.69% or 1 in 144 per 2018 national survey
24
Global ASD cases projected to reach 111 million children by 2028 per WHO
25
In Missouri U.S., ASD prevalence 1 in 52 for 8-year-olds per CDC 2020
26
Adult ASD prevalence in U.S. estimated 2.3% per 2021 study
27
In Brazil, ASD prevalence around 0.27% but likely underestimated
28
Scottish children ASD rate 1.65% or 1 in 61 per 2019 data
29
In Utah U.S., ASD prevalence 1 in 32 highest among CDC sites 2020
30
Ireland ASD prevalence 1.5% in children per 2020 HSE report
Interpretation
Epidemiology And Prevalence Interpretation
Epidemiology and prevalence data show autism identification has risen sharply in the United States from about 1 in 150 children in 2000 to about 1 in 36 in 2020, indicating growing prevalence estimates driven by improved awareness and diagnosis.
More related reading
report visual · Projection
ASD identification prevalence among 8-year-old children, US
Over time, ASD identification prevalence increased—moving from about 1 in 150 (2000) to about 1 in 36 (2020), indicating a large rise in the share of 8-year-olds identified with AS
150 1 in X children
Start
-6.89%
CAGR · 20y
36 1 in X children
Projected
20002020
source-verifiedcdc.gov2020
04 · Category
Etiology And Genetics30 stats
01
Heritability of ASD estimated at 80% from twin studies
02
Over 100 genes associated with ASD risk per SFARI Gene database 2023
03
De novo mutations contribute 10-30% ASD cases per exome sequencing
04
CHD8 gene mutations cause 0.5% ASD with macrocephaly
05
Fragile X syndrome accounts for 1-2% ASD cases
06
Prenatal valproic acid exposure increases ASD risk 10-fold
07
Advanced parental age raises ASD risk: fathers >50 odds ratio 1.5
08
Maternal obesity (BMI>30) ASD risk OR 1.64 per meta-analysis
09
Air pollution PM2.5 exposure prenatal OR 1.12 for ASD
10
Copy number variants (CNVs) in 10-15% ASD per studies
11
SHANK3 mutations in 1-2% ASD with Phelan-McDermid syndrome
12
Maternal immune activation (MIA) model replicates ASD traits in mice
13
Gestational diabetes OR 1.42 for ASD per large cohorts
14
Pesticide exposure (organophosphates) prenatal OR 1.6 ASD risk
15
TSC1/TSC2 mutations cause 1-4% syndromic ASD (Tuberous Sclerosis)
16
Epigenetic changes (DNA methylation) linked to 20% ASD variance
17
Brother of autistic sibling risk 18%, sister 8% vs population 1%
18
No MMR vaccine-ASD link confirmed in 1.2M child Danish study OR 0.93
19
FMR1 premutation in 1% fragile X premutation carriers have ASD
20
MET gene variants increase ASD risk OR 2.28 in families
21
Prenatal acetaminophen exposure OR 1.2-2.0 ASD risk per studies
22
15q11-q13 duplication in 1% ASD cases
23
Maternal fever during pregnancy OR 1.4 ASD if untreated
24
Polygenic risk scores explain 5-10% ASD heritability
25
Assisted reproductive tech slight increase OR 1.1-1.3 ASD risk
26
Zinc deficiency prenatal linked to ASD via synaptic function
27
NRXN1 deletions in 0.5-1% ASD
28
Gut microbiome dysbiosis precedes ASD symptoms in infants
29
Birth asphyxia severe increases ASD OR 4.3
30
Vitamin D deficiency maternal OR 1.75 ASD risk
Interpretation
Etiology And Genetics Interpretation
Twin studies estimate autism spectrum disorder heritability at about 80%, and with over 100 ASD risk genes plus de novo mutations explaining roughly 10 to 30% of cases, genetics clearly plays a dominant etiological role even as specific exposures like prenatal valproic acid raise risk by about 10-fold.
05 · Category
Interventions And Support30 stats
01
Intensive ABA therapy 20-40 hours/week improves IQ 15-20 points average
02
Early Start Denver Model (ESDM) at 12-48 months gains 17 IQ points
03
Risperidone reduces irritability 69% in ASD youth per RUPP trial
04
Speech therapy improves communication 50% in verbal ASD children
05
TEACCH structured teaching reduces behaviors 45% per meta-analysis
06
Oxytocin nasal spray improves social skills temporarily 50% trials
07
Floortime/PLAY increases social engagement 47% per studies
08
Social skills training effect size 0.45 medium per 2018 review
09
Aripiprazole reduces ABC-Irritability 52% in ASD 6-17 years
10
Pivotal Response Treatment (PRT) vocab gains 20 words/month
11
CBT for anxiety in high-functioning ASD 68% response rate
12
Sensory integration therapy reduces SPD symptoms 57% per RCT
13
Vocational training employment rate 58% post-high school ASD
14
Melatonin improves sleep onset 34 minutes faster in ASD
15
PECS picture exchange increases requests 80% non-verbal ASD
16
Parent training (PRISM) reduces disruptive behavior 50%
17
Music therapy improves communication skills effect size 0.77
18
Bumetanide diuretic improves ASD symptoms 50% in trial subset
19
Exercise interventions reduce stereotypies 30-50% per meta-analysis
20
Supported employment 55% ASD adults competitive jobs with support
21
Propranolol reduces self-injurious behavior 60% open trial
22
DIR/Floortime 30% improvement emotional development
23
N-acetylcysteine reduces irritability effect size 0.5
24
Peer-mediated intervention social initiations +200%
25
Guanfacine adjunct reduces ADHD symptoms 40% ASD
26
Animal-assisted therapy reduces anxiety 24% ASD children
27
Virtual reality social training improves skills 40%
28
Stem cell therapy pilot improvements in 70% CARS score
29
Mindfulness training reduces anxiety 31% high-functioning ASD
30
Comprehensive programs like Lovaas ABA 47% best outcome "normal"
Interpretation
Interventions And Support Interpretation
Interventions and support can make a measurable difference, with early and intensive approaches like 20 to 40 hours per week of ABA raising IQ by about 15 to 20 points and structured teaching or targeted therapies cutting key symptoms by roughly 45% to 69% depending on the method.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Leah Kessler. (2026, February 13). Autism Statistics. Gitnux. https://gitnux.org/autism-statistics
MLA
Leah Kessler. "Autism Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/autism-statistics.
Chicago
Leah Kessler. 2026. "Autism Statistics." Gitnux. https://gitnux.org/autism-statistics.